Innovative Designer Peptides to Treat Cardiovascular, Metabolic & Kidney Disease
OUR SCIENCE
MANP, our innovative GC-A receptor activator, pioneers hypertension research
OUR TEAM
Our greatest health science breakthroughs occurred because someone was bold enough to challenge the status quo
Our Clinical Studies
The BOLD-HTN Study advances our understanding of MANP as a novel GC-A activating designer peptide for uncontrolled blood pressure. This Phase 2 clinical trial lays the foundation for its development as an innovative medicine for hypertension.
Check out our news and publications
Featured
